
IndraLab
Statements
reach
"In a physiological study in INS-1 cell cultures, the blockade of the KvLQT1 channel with KCNQ1 protein inhibitor 293B stimulated insulin secretion in the presence of sulphonylurea drug tolbutamide [XREF_BIBR], suggesting that KvLQT1 channels might play a role in fine tuning of insulin secretion during sulphonylurea treatment."
reach
"In contrast, it was reported that an inhibitor of KCNQ1 (chromanol 293B) significantly increased insulin secretion in the presence of sulfonylurea; this finding suggested that the activity of KCNQ1 in subjects with the C allele of rs2237897, a risk allele for type 2 diabetes, might be higher than that in subjects with the T allele, a risk allele for diabetic nephropathy in the present study."
reach
"Inhibition of KCNQ1 channel activity by the selective inhibitor chromanol 293B significantly increases insulin secretion in INS-1 cells XREF_BIBR, whereas KCNQ1 overexpression in MIN6 cells results in markedly impaired insulin secretion by glucose, pyruvate, or tolbutamide XREF_BIBR."